Cargando…

An Update on the Application of CRISPR Technology in Clinical Practice

The CRISPR/Cas system, an innovative gene-editing tool, is emerging as a promising technique for genome modifications. This straightforward technique was created based on the prokaryotic adaptive immune defense mechanism and employed in the studies on human diseases that proved enormous therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Morshedzadeh, Firouzeh, Ghanei, Mahmoud, Lotfi, Malihe, Ghasemi, Morteza, Ahmadi, Mohsen, Najari-Hanjani, Parisa, Sharif, Samaneh, Mozaffari-Jovin, Sina, Peymani, Maryam, Abbaszadegan, Mohammad Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239226/
https://www.ncbi.nlm.nih.gov/pubmed/37269466
http://dx.doi.org/10.1007/s12033-023-00724-z
_version_ 1785053455301214208
author Morshedzadeh, Firouzeh
Ghanei, Mahmoud
Lotfi, Malihe
Ghasemi, Morteza
Ahmadi, Mohsen
Najari-Hanjani, Parisa
Sharif, Samaneh
Mozaffari-Jovin, Sina
Peymani, Maryam
Abbaszadegan, Mohammad Reza
author_facet Morshedzadeh, Firouzeh
Ghanei, Mahmoud
Lotfi, Malihe
Ghasemi, Morteza
Ahmadi, Mohsen
Najari-Hanjani, Parisa
Sharif, Samaneh
Mozaffari-Jovin, Sina
Peymani, Maryam
Abbaszadegan, Mohammad Reza
author_sort Morshedzadeh, Firouzeh
collection PubMed
description The CRISPR/Cas system, an innovative gene-editing tool, is emerging as a promising technique for genome modifications. This straightforward technique was created based on the prokaryotic adaptive immune defense mechanism and employed in the studies on human diseases that proved enormous therapeutic potential. A genetically unique patient mutation in the process of gene therapy can be corrected by the CRISPR method to treat diseases that traditional methods were unable to cure. However, introduction of CRISPR/Cas9 into the clinic will be challenging because we still need to improve the technology's effectiveness, precision, and applications. In this review, we first describe the function and applications of the CRISPR–Cas9 system. We next delineate how this technology could be utilized for gene therapy of various human disorders, including cancer and infectious diseases and highlight the promising examples in the field. Finally, we document current challenges and the potential solutions to overcome these obstacles for the effective use of CRISPR–Cas9 in clinical practice.
format Online
Article
Text
id pubmed-10239226
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-102392262023-06-06 An Update on the Application of CRISPR Technology in Clinical Practice Morshedzadeh, Firouzeh Ghanei, Mahmoud Lotfi, Malihe Ghasemi, Morteza Ahmadi, Mohsen Najari-Hanjani, Parisa Sharif, Samaneh Mozaffari-Jovin, Sina Peymani, Maryam Abbaszadegan, Mohammad Reza Mol Biotechnol Review Paper The CRISPR/Cas system, an innovative gene-editing tool, is emerging as a promising technique for genome modifications. This straightforward technique was created based on the prokaryotic adaptive immune defense mechanism and employed in the studies on human diseases that proved enormous therapeutic potential. A genetically unique patient mutation in the process of gene therapy can be corrected by the CRISPR method to treat diseases that traditional methods were unable to cure. However, introduction of CRISPR/Cas9 into the clinic will be challenging because we still need to improve the technology's effectiveness, precision, and applications. In this review, we first describe the function and applications of the CRISPR–Cas9 system. We next delineate how this technology could be utilized for gene therapy of various human disorders, including cancer and infectious diseases and highlight the promising examples in the field. Finally, we document current challenges and the potential solutions to overcome these obstacles for the effective use of CRISPR–Cas9 in clinical practice. Springer US 2023-06-03 /pmc/articles/PMC10239226/ /pubmed/37269466 http://dx.doi.org/10.1007/s12033-023-00724-z Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Review Paper
Morshedzadeh, Firouzeh
Ghanei, Mahmoud
Lotfi, Malihe
Ghasemi, Morteza
Ahmadi, Mohsen
Najari-Hanjani, Parisa
Sharif, Samaneh
Mozaffari-Jovin, Sina
Peymani, Maryam
Abbaszadegan, Mohammad Reza
An Update on the Application of CRISPR Technology in Clinical Practice
title An Update on the Application of CRISPR Technology in Clinical Practice
title_full An Update on the Application of CRISPR Technology in Clinical Practice
title_fullStr An Update on the Application of CRISPR Technology in Clinical Practice
title_full_unstemmed An Update on the Application of CRISPR Technology in Clinical Practice
title_short An Update on the Application of CRISPR Technology in Clinical Practice
title_sort update on the application of crispr technology in clinical practice
topic Review Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239226/
https://www.ncbi.nlm.nih.gov/pubmed/37269466
http://dx.doi.org/10.1007/s12033-023-00724-z
work_keys_str_mv AT morshedzadehfirouzeh anupdateontheapplicationofcrisprtechnologyinclinicalpractice
AT ghaneimahmoud anupdateontheapplicationofcrisprtechnologyinclinicalpractice
AT lotfimalihe anupdateontheapplicationofcrisprtechnologyinclinicalpractice
AT ghasemimorteza anupdateontheapplicationofcrisprtechnologyinclinicalpractice
AT ahmadimohsen anupdateontheapplicationofcrisprtechnologyinclinicalpractice
AT najarihanjaniparisa anupdateontheapplicationofcrisprtechnologyinclinicalpractice
AT sharifsamaneh anupdateontheapplicationofcrisprtechnologyinclinicalpractice
AT mozaffarijovinsina anupdateontheapplicationofcrisprtechnologyinclinicalpractice
AT peymanimaryam anupdateontheapplicationofcrisprtechnologyinclinicalpractice
AT abbaszadeganmohammadreza anupdateontheapplicationofcrisprtechnologyinclinicalpractice
AT morshedzadehfirouzeh updateontheapplicationofcrisprtechnologyinclinicalpractice
AT ghaneimahmoud updateontheapplicationofcrisprtechnologyinclinicalpractice
AT lotfimalihe updateontheapplicationofcrisprtechnologyinclinicalpractice
AT ghasemimorteza updateontheapplicationofcrisprtechnologyinclinicalpractice
AT ahmadimohsen updateontheapplicationofcrisprtechnologyinclinicalpractice
AT najarihanjaniparisa updateontheapplicationofcrisprtechnologyinclinicalpractice
AT sharifsamaneh updateontheapplicationofcrisprtechnologyinclinicalpractice
AT mozaffarijovinsina updateontheapplicationofcrisprtechnologyinclinicalpractice
AT peymanimaryam updateontheapplicationofcrisprtechnologyinclinicalpractice
AT abbaszadeganmohammadreza updateontheapplicationofcrisprtechnologyinclinicalpractice